文献速递主动脉疾病

双开窗与三或四开窗腔内修复复杂腹主动脉瘤结局比较

Comparison of outcomes for double fenestrated endovascular aneurysm repair versus triple or quadruple fenestrated endovascular aneurysm repair in the treatment of complex abdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2017-02-08

本研究比较仅肾动脉开窗的标准开窗腔内修复(St-FEVAR)与额外肠系膜上动脉或腹腔干开窗的复杂开窗腔内修复(Co-FEVAR)的结局。纳入2010年1月至2016年7月间连续384例患者,St-FEVAR组199例、Co-FEVAR组185例。结果显示两组围术期死亡率和主要并发症相似,Co-FEVAR手术时间和透视时间更长,但技术成功率不劣于St-FEVAR。

要点

  • Co-FEVAR与St-FEVAR的30天死亡率(均为0.5%)和主要围术期并发症(11.1% vs 13%)无显著差异。
  • Co-FEVAR组平均手术时间(176分钟 vs 135分钟)和透视时间(57分钟 vs 45分钟)均显著长于St-FEVAR组。
  • 两组1年和3年生存率、免于再干预率及靶血管通畅率均无显著差异。

核心结论

  • Co-FEVAR与St-FEVAR相比不增加围术期死亡率和并发症。
  • Co-FEVAR需要更长的手术和透视时间,但技术成功率与St-FEVAR相当。
  • 当需要更长更高的近端锚定区时,合理使用Co-FEVAR是合理的。

研究设计与样本

  • 回顾性比较研究,纳入2010年1月至2016年7月连续384例接受FEVAR治疗的短颈、近肾或肾上主动脉瘤患者。
  • St-FEVAR组199例(51.8%),Co-FEVAR组185例(48.2%),其中30例为四开窗FEVAR。
  • 排除开窗与分支联合使用的支架移植物患者,数据前瞻性收集。

临床怎么用

  • 对于复杂腹主动脉瘤需要更长更高近端锚定区时,可合理选择Co-FEVAR而不必担心增加围术期风险。
  • 应预期Co-FEVAR手术时间和透视时间更长,需做好相应资源准备。

局限性

  • 本研究为单中心回顾性分析,随访时间有限(平均20个月)。
  • 排除开窗与分支联合使用的患者,结论可能不适用于所有复杂腹主动脉瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study compared outcomes of standard fenestrated endovascular aneurysm repair (St-FEVAR) with renal artery fenestrations only with more complex FEVAR (Co-FEVAR) with additional fenestrations for the superior mesenteric artery or the celiac trunk, or both. METHODS: All consecutive patients treated with FEVAR for short-necked, juxtarenal, or suprarenal aortic aneurysms between January 2010 and July 2016 were included. Patients with stent grafts with a combination of fenestrations and branches were excluded. Data were collected prospectively. All stent grafts used were customized based on the Zenith system (William A. Cook Australia, Ltd, Brisbane, Queensland, Australia). RESULTS: A total of 384 patients (345 men; mean age, 72.7 ± 7.8 years) were treated. St-FEVAR was used in 199 patients (51.8%) and Co-FEVAR in 185 (48.2%), including 30 patients with a quadruple FEVAR. Overall technical success was 373 of 384 (97.1%), and the difference between the St-FEVAR group (195 of 199 [98%]) and the Co-FEVAR group (178 of 185 [96.2%]) was not statistically significant (P = .37). Mean operative time was 135 ± 46 minutes for St-FEVAR and 176 ± 53 minutes for Co-FEVAR (P < .001). Mean fluoroscopy time was 45 ± 17 minutes for St-FEVAR and 57 ± 21 minutes for Co-FEVAR (P < .001). Overall 30-day mortality was two of 384 (0.5%), and the difference between the two groups was not statistically significant (St-FEVAR: 1 of 199 [0.5%] vs Co-FEVAR: 1 of 185 [0.5%]; P = 1.0). Major perioperative complications between St-FEVAR group (22 of 199 [11.1%]) and Co-FEVAR group (24 of 185 [13%]) were similar (P = .64). Mean follow-up was 20 ± 17.1 months. Estimated survival at 1 and 3 years was 95% ± 1.7% and 83.4% ± 3.6% for St-FEVAR vs 94% ± 2.4% and 89.4% ± 3.5%, respectively, for Co-FEVAR (P = .96). Estimated freedom from reintervention at 1 and 3 years was 97.9% ± 1.2% and 90.5% ± 3.1% for St-FEVAR vs 95.4% ± 2.0% and 89.1% ± 4.2%, respectively, for Co-FEVAR (P = .5). Estimated target vessel patency at 1 and 3 years was 99.2% ± 0.4% and 98.6.0% ± 0.6% for St-FEVAR vs 98.6% ± 0.6% and 97.9% ± 0.9%, respectively, for Co-FEVAR (P = .48). CONCLUSIONS: Co-FEVAR is not associated with an increase in perioperative mortality and morbidity compared with St-FEVAR. Co-FEVAR requires longer procedure and fluoroscopy duration, but technical success rates are as high as in St-FEVAR. A liberal use of Co-FEVAR is therefore justified whenever a longer and higher proximal sealing zone is needed.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Katsargyris A, Oikonomou K, Kouvelos G, et al. Comparison of outcomes for double fenestrated endovascular aneurysm repair versus triple or quadruple fenestrated endovascular aneurysm repair in the treatment of complex abdominal aortic aneurysms. J Vasc Surg. 2017. PMID: 28189357. doi:10.1016/j.jvs.2016.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。